---
title: "Alphatec | 8-K: FY2025 Q3 Revenue Beats Estimate at USD 196.5 M"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/263604716.md"
datetime: "2025-10-30T20:54:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263604716.md)
  - [en](https://longbridge.com/en/news/263604716.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263604716.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/263604716.md) | [English](https://longbridge.com/en/news/263604716.md)


# Alphatec | 8-K: FY2025 Q3 Revenue Beats Estimate at USD 196.5 M

Revenue: As of FY2025 Q3, the actual value is USD 196.5 M, beating the estimate of USD 182.63 M.

EPS: As of FY2025 Q3, the actual value is USD -0.19, missing the estimate of USD -0.1633.

EBIT: As of FY2025 Q3, the actual value is USD -15.93 M.

### Financial Metrics by Segment

#### Segment Revenue

-   Total revenue grew $46 million or 30% to $197 million.
-   Surgical revenue grew 31% to $177 million.

#### Operational Metrics

-   GAAP gross margin: 70%.
-   Non-GAAP gross margin: 70%.
-   GAAP operating expenses: $153 million.
-   Non-GAAP operating expenses: $127 million.
-   GAAP net income / (loss): - $29 million.
-   Non-GAAP net income / (loss): $4 million.
-   Adjusted EBITDA: $26 million.
-   Adjusted EBITDA margin: 13%.

#### Cash Flow

-   Ending cash balance: $156 million.
-   Generated $5 million in free cash flow in the quarter and is free cash flow positive the trailing twelve months.

#### Unique Metrics

-   EOS revenue of $20 million grew by 29% YoY as EOS Insight® adoption increased.
-   Achieved 26% growth in net new surgeon users, a key leading indicator of future growth.

### Outlook / Guidance

-   For the fiscal year ending December 31, 2025, the Company now expects total revenue to grow 24% to $760 million compared to the previous expectation of $742 million.
-   This includes surgical revenue of $684 million and EOS revenue of $76 million.
-   The Company now expects non-GAAP adjusted EBITDA of approximately $91 million compared to the previous expectation of $83 million.

### 相關股票

- [Alphatec (ATEC.US)](https://longbridge.com/zh-HK/quote/ATEC.US.md)

## 相關資訊與研究

- [Alphatec Holdings Grants 67,643 RSUs to New Employees as Inducement Awards](https://longbridge.com/zh-HK/news/272282884.md)
- [Alphatec Holdings CEO Patrick Miles Reports Sale of Common Shares](https://longbridge.com/zh-HK/news/271711743.md)
- [Alphatec Holdings Officer Sells Shares](https://longbridge.com/zh-HK/news/278436292.md)
- [Alphatec Holdings CEO Sells 100,000 Shares](https://longbridge.com/zh-HK/news/271712882.md)
- [Alphatec Holdings Secures Exclusive U.S. Rights to Theradaptive's OsteoAdapt Platform](https://longbridge.com/zh-HK/news/272285784.md)